Found 17 matching trials
Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy PHASE1 Study WCMC IST/VOS/MDS evaluates the safety and tolerability of escalating ...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes PHASE1 This phase I trial studies the side effects and the best dose of vosaroxin ...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans PHASE1 This study will evaluate the safety and tolerability of voreloxin (vosaroxi...
Show More Location
HealthOne Presbyterian/St. Luke's Medical Center
Learn More & Join Trial
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML PHASE3 This study compared treatment groups of patients treated with vosaroxin and...
Show More Location
Moores UCSD Cancer Center
Learn More & Join Trial
Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2 PHASE2 The main part of this trial is a phase II study of vosaroxin with azacitidi...
Show More Location
Kliniken Essen-Süd, Evang. Krankenhaus Essen-Werden gGmbH
Learn More & Join Trial
Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia PHASE2 This study will evaluate the overall remission rate of treatment with vosar...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations PHASE2 The AML18 Trial will evaluate several relevant therapeutic questions in Acu...
Show More Location
Aalborg University Hospital
Learn More & Join Trial
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR PHASE2 This open label, multicenter phase II/III study with multiple randomization...
Show More Location
CH Amiens Hôpital Sud
Learn More & Join Trial
Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia PHASE2 This phase II trial studies how well vosaroxin and cytarabine work in treat...
Show More Learn More & Join Trial
Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors. PHASE1 The purpose of this study is to determine whether SNS-595 given intravenous...
Show More Location
Arizona Cancer Center
Learn More & Join Trial